Non-myeloablative allogeneic haemopoietic stem-cell transplantation for treatment of metastatic invasive thymoma

Lancet Oncology

Volumn 6, Issue 8, 2005, Pages 626-628

  Numata, Akihiko ^a   Yasuda, Keiko ^a   Fukuda, Takahiro ^b   Baba, Eishi ^a   Yamasaki, Satoshi ^a   Takase, Ken ^a   Miyamoto, Toshihiro ^a   Nagafuji, Koji ^a   Nakano, Shuji ^a   Harada, Mine ^a  

^a KYUSHU UNIVERSITY HOSPITAL   (Japan)

^b NATIONAL CANCER CENTER HOSPITAL   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CISPLATIN; CYCLOPHOSPHAMIDE; CYCLOSPORIN A; DOXORUBICIN; FLUDARABINE; METHOTREXATE; PREDNISOLONE; RECOMBINANT GRANULOCYTE COLONY STIMULATING FACTOR; VINCRISTINE;

ACUTE GRAFT VERSUS HOST DISEASE; ADULT; ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION; ALLOGENEIC PERIPHERAL BLOOD STEM CELL TRANSPLANTATION; ANAMNESIS; ARTICLE; BLOOD GROUP ABO INCOMPATIBILITY; CANCER COMBINATION CHEMOTHERAPY; CANCER RELAPSE; CASE REPORT; CHRONIC GRAFT VERSUS HOST DISEASE; COMPUTER ASSISTED TOMOGRAPHY; ERYTHROCYTE APLASIA; ERYTHROCYTE COUNT; ERYTHROPOIESIS; FEMALE; FOLLOW UP; HLA TYPING; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY FAILURE; NEUTROPHIL; NONMYELOABLATIVE CONDITIONING; PRIORITY JOURNAL; PROGNOSIS; PURE RED CELL ANEMIA; RETICULOCYTE COUNT; T LYMPHOCYTE; THYMOMA;

ADULT; FEMALE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; NEOPLASM INVASIVENESS; NEOPLASM METASTASIS; THYMOMA; THYMUS NEOPLASMS; TRANSPLANTATION, HOMOLOGOUS;

EID: 22944486402     PISSN: 14702045     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1470-2045(05)70285-0     Document Type: Article

References (10)

1. Thomas CR Wright CD Loehrer PJ Thymoma: State of the art J Clin Oncol 17 1999 2280-2289
2. N Hanna VS Gharpure R Abonour et al. High-dose carboplatin with etoposide in patients with recurrent thymoma: The Indiana University experience Bone Marrow Transplant 28 2001 435-438
3. Y Iwasaki S Ohsugi Y Takemura et al. Multidisciplinary therapy including high-dose chemotherapy followed by peripheral blood stem cell transplantation for invasive thymoma Chest 122 2002 2249-2252
4. S Giralt E Estey M Albitar et al. Engraftment of allogeneic hematopoietic progenitor cells with purine analog-containing chemotherapy: Harnessing graft-versus-leukemia without myeloablative therapy Blood 89 1997 4531-4536
5. S Slavin A Nagler E Naparstek et al. Nonmyeloablative stem cell transplantation and cell therapy as an alternative to conventional bone marrow transplantation with lethal cytoreduction for the treatment of malignant and nonmalignant hematologic diseases Blood 91 1998 756-763
6. R Childs A Chernoff N Contentin et al. Regression of metastatic renal-cell carcinoma after nonmyeloablative allogeneic peripheral-blood stem-cell transplantation N Engl J Med 343 2000 750-758
7. I Espinoza-Delgado RW Childs Nonmyeloablative transplantation for solid tumors: A new frontier for allogeneic immunotherapy Expert Rev Anticancer Ther 4 2004 865-8753
8. BU Muller A Tichelli JR Passweg et al. Successful treatment of refractory acquired pure red cell aplasia (PRCA) by allogeneic bone marrow transplantation Bone Marrow Transplant 23 1999 1205-1257
9. M Musso F Porretto A Crescimanno et al. Donor lymphocyte infusions for refractory pure red cell aplasia relapsing after both autologous and nonmyeloablative allogeneic peripheral stem cell transplantation Bone Marrow Transplant 33 2004 769-771
10. CD Bolan SF Leitman LM Griffith et al. Delayed donor red cell chimerism and pure red cell aplasia following major ABO-incompatible nonmyeloablative hematopoietic stem cell transplantation Blood 98 2001 1687-1694